Search results for: glioblastoma multiforme

• Novel NK1R-Targeted 68Ga-/177Lu-Radioconjugates with Potential Application against Glioblastoma Multiforme: Preliminary Exploration of Structure–Activity Relationships

  Publication

  • P. Lipiński

  - International Journal of Molecular Sciences - Year 2022

  Full text to download in external service

• Inhibition of T-type calcium channel disrupts Akt signaling and promotes apoptosis in glioblastoma cells.

  Publication

  • N. C. Valerie
  • B. Dziegielewska
  • A. S. Hosing
  • E. Augustin
  • L. S. Gray
  • D. L. Brautigan
  • J. M. Larner
  • J. Dziegielewski

  - BIOCHEMICAL PHARMACOLOGY - Year 2013

  Glioblastoma multiforme (GBM) are brain tumors that are exceptionally resitant to both radio- and chemotherapy regimens and novel approaches to treatment are needed. T-type calcium channels are one type of low voltage-gated channel (LVCC) involved in embryonic cell proliferation and differentiation; however they are often over-expressed in tumors, including GBM. In this study, we found that inhibition of T-type Ca channels in GBM...

  Full text to download in external service

• Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies

  Publication

  • M. Houweling
  • A. Giczewska
  • A. Kulsoom
  • N. Nieuwenhuis
  • A. Küçükosmanoglu
  • K. Pastuszak
  • R. C. Buijsman
  • P. Wesseling
  • L. Wedekind
  • D. Noske... and 5 others

  - Neuro-Oncology Advances - Year 2023

  Abstract Background IDH-wildtype glioblastoma (GBM) is a highly malignant primary brain tumor with a median survival of 15 months after standard of care, which highlights the need for improved therapy. Personalized combination therapy has shown to be successful in many other tumor types and could be beneficial for GBM patients. Methods We performed the largest drug combination screen to date in GBM, using a high-throughput effort...

  Full text available to download